Document Detail


Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis.
MedLine Citation:
PMID:  19279015     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To measure the prevalence of, and factors associated with, left ventricular (LV) dysfunction in systemic sclerosis (SSc). METHODS: The EUSTAR database was first searched. A case-control study of a patient subset was then performed to further identify independent factors associated with LV dysfunction by simple and multiple regression. RESULTS: Of 7073 patients, 383 (5.4%) had an LV ejection fraction (EF) of <55%. By multiple regression analysis, age, sex, diffuse cutaneous disease, disease duration, digital ulcerations, renal and muscle involvement, disease activity score, pulmonary fibrosis and pulmonary arterial hypertension were associated with LV dysfunction. In the second phase, 129 patients with SSc with LVEF <55% were compared with 256 patients with SSc with normal LVEF. Male sex (OR 3.48; 95% CI 1.74 to 6.98), age (OR 1.03; 95% CI 1.01 to 1.06), digital ulcerations (OR 1.91; 95% CI 1.05 to 3.50), myositis (OR 2.88; 95% CI 1.15 to 7.19) and use of calcium channel blockers (OR 0.41; 95% CI 0.22 to 0.74) were independent factors associated with LV dysfunction. CONCLUSION: The prevalence of LV dysfunction in SSc is 5.4%. Age, male gender, digital ulcerations, myositis and lung involvement are independently associated with an increased prevalence of LV dysfunction. Conversely, the use of calcium channel blockers may be protective.
Authors:
Y Allanore; C Meune; M C Vonk; P Airo; E Hachulla; P Caramaschi; G Riemekasten; F Cozzi; L Beretta; C T Derk; A Komócsi; D Farge; A Balbir; V Riccieri; O Distler; A Chialà; N Del Papa; K Pasalic Simic; M Ghio; B Stamenkovic; S Rednic; N Host; R Pellerito; E Zegers; A Kahan; U A Walker; M Matucci-Cerinic;
Related Documents :
19435825 - Impact of resistance to thyroid hormone on the cardiovascular system in adults.
9388095 - Comparison of left ventricular function and volumes during transesophageal atrial pacin...
16596835 - Prognosis of patients with left ventricular diastolic pressure abnormality: a long-term...
2958575 - Electrocardiographic diagnosis of left ventricular hypertrophy in the presence of left ...
14985665 - Testicular dislocation: an uncommon and easily overlooked complication of blunt abdomin...
8162135 - Speech and swallowing symptoms associated with parkinson's disease and multiple scleros...
Publication Detail:
Type:  Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Annals of the rheumatic diseases     Volume:  69     ISSN:  1468-2060     ISO Abbreviation:  Ann. Rheum. Dis.     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2009-12-16     Completed Date:  2010-02-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372355     Medline TA:  Ann Rheum Dis     Country:  England    
Other Details:
Languages:  eng     Pagination:  218-21     Citation Subset:  IM    
Affiliation:
Service de Rhumatologie A, Hôpital Cochin, Université Paris Descartes, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France. yannick.allanore@cch.aphp.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Age Factors
Aged
Calcium Channel Blockers / therapeutic use
Epidemiologic Methods
Europe / epidemiology
Female
Fingers
Humans
Male
Middle Aged
Myositis / complications,  epidemiology
Scleroderma, Systemic / complications*,  epidemiology
Sex Factors
Skin Ulcer / complications,  epidemiology
Stroke Volume
Ventricular Dysfunction, Left / epidemiology,  etiology*,  prevention & control
Chemical
Reg. No./Substance:
0/Calcium Channel Blockers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The Crystal Structure of Aquifex aeolicus Prephenate Dehydrogenase Reveals the Mode of Tyrosine Inhi...
Next Document:  Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfu...